Aesthetic Medical International Holdings Group (Aesthetic Medical International Holdings Group) Cash-to-Debt : 0.28 (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Aesthetic Medical International Holdings Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Aesthetic Medical International Holdings Group's cash to debt ratio for the quarter that ended in Jun. 2023 was 0.28.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Aesthetic Medical International Holdings Group couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

The historical rank and industry rank for Aesthetic Medical International Holdings Group's Cash-to-Debt or its related term are showing as below:

AIH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 0.11 Max: 0.45
Current: 0.28

During the past 7 years, Aesthetic Medical International Holdings Group's highest Cash to Debt Ratio was 0.45. The lowest was 0.03. And the median was 0.11.

AIH's Cash-to-Debt is ranked worse than
65.34% of 655 companies
in the Healthcare Providers & Services industry
Industry Median: 0.74 vs AIH: 0.28

Aesthetic Medical International Holdings Group Cash-to-Debt Historical Data

The historical data trend for Aesthetic Medical International Holdings Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Aesthetic Medical International Holdings Group Cash-to-Debt Chart

Aesthetic Medical International Holdings Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

0.12

0.45

0.10

0.03

Aesthetic Medical International Holdings Group Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Cash-to-Debt	Get a 7-Day Free Trial															0.06	0.05	0.03	0.34	0.28

Competitive Comparison of Aesthetic Medical International Holdings Group's Cash-to-Debt

For the Medical Care Facilities subindustry, Aesthetic Medical International Holdings Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aesthetic Medical International Holdings Group's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aesthetic Medical International Holdings Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Aesthetic Medical International Holdings Group's Cash-to-Debt falls into.

Aesthetic Medical International Holdings Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Aesthetic Medical International Holdings Group's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.744	/	(37.965	+	18.419)
	=	0.03

Aesthetic Medical International Holdings Group's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	12.271	/	(28.471	+	16.058)
	=	0.28

Aesthetic Medical International Holdings Group (NAS:AIH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Aesthetic Medical International Holdings Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Aesthetic Medical International Holdings Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Aesthetic Medical International Holdings Group (Aesthetic Medical International Holdings Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aesthetic Medical International Holdings Group Ltd (NAS:AIH) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

3FMA:Germany 3FMA:Germany

Address

1122 Nanshan Boulevard, Nanshan District, Guangdong Province, Shenzhen, CHN, 518052

Website

https://ir.aihgroup.net

Aesthetic Medical International Holdings Group Ltd provides aesthetic medical services in China. The company generates revenue from four service offerings: non-surgical aesthetic medical services, surgical aesthetic medical services, other aesthetic medical services, and general healthcare services in the People's Republic of China. The company derives a majority of its revenue from Non-surgical aesthetic medical services. Geographically, it derives revenue from China.